11:00am ET
Health and Healthcare
Short Sellers Starting to Gang Up on Biotech
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected stocks, short interest is down.
AMGN Coverage Page 31
8:55am ET
Health and Healthcare
Short Interest in Biotechs Signals Optimism
24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.
1:05pm ET
Health and Healthcare
Is a Biosimilar (Generic) Top Cancer Drug for You?
A biosimilar application filing from Apotex has been accepted by the Food and Drug Administration for version of Amgen's Neulasta.
10:00am ET
Health and Healthcare
Are Investors Signaling Optimism in Biotechs Through Short Interest?
The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top biotech companies.
11:07am ET
Health and Healthcare
Mixed Readings For Biotech Short Interest
ThinkstockThe short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or…
10:23am ET
Health and Healthcare
Amgen Surprise, Discontinues Stomach Cancer Drug Study
ThinkstockAmgen Inc. (NASDAQ: AMGN) announced the termination of all Amgen-sponsored clinical studies of rilotumumab in advanced gastric cancer. This includes phase 3 RILOMET-1 and RILOMET-2 studies. The decision to discontinue was made…
Chris Lange 8:40am ET
Health and Healthcare
Biotech Short Interest Becomes Stock Specific (Updated)
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.
8:55am ET
Health and Healthcare
Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings
A new research note from Cowen focuses on health care companies that have released earnings and offer investors reasons to own the stocks.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, October 29, 2014.
4:33pm ET
Health and Healthcare
Amgen Posts 52-Week High, Beats It Again After Earnings
Amgen reported better-than-expected third-quarter 2014 results after markets closed Monday afternoon.
Paul Ausick 10:30am ET
Health and Healthcare
Biotech Short Interest Becomes Stock Specific
Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.
4:22pm ET
Health and Healthcare
The Plan to Drive Amgen Shares Up Over 70%
Amgen Inc. (NASDAQ: AMGN) used to be the king of biotech by size. That was then, and now is the time for a break-up or other efforts. At least that is the…
Jon C. Ogg 8:40am ET
Health and Healthcare
UBS Very Positive on Top Biotech Stocks Ahead of Earnings
Rising trends in prescriptions and higher, yet beatable increases in earnings have set the table for what the UBS biotech analysts feels could be a very solid third-quarter earnings season.
10:10am ET
Health and Healthcare
Short Interest in Biotech Becomes Company Specific
The short interest data are out for the end of September settlement date, and 24/7 Wall St. has reviewed the top biotech companies.
8:30am ET
Health and Healthcare
3 Likely Biotech Buyout Candidates
A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could be of the blockbuster variety.